Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-507-1 | CAS number: 1137-42-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Urine concentrations in male humans were negatively associated with fecundability (Louis et al., American Journal of Epidemiology, 2014, Vol. 180, No. 12).
4OH-BP was detected in human urine. No significant semen quality endpoint associations (odd ratio) were observed for urinary concentrations of 4OH-BP in humans (Louis et al., Fertil Steril 2015, 104:989–96).
There were no statistically significant differences (Spearman correlation) between human children malformation cases and controls in the median placenta concentration of 4-OH-BP (Fernandez et al., Reproductive Toxicology 59, 2016, 89–95)
4-OH-BP was detectable in human urine, amniotic fluid and cord blood samples but not in paired fetal blood (Krause et al., Environment International 110, 2018, 51-60).
None of the 15 tested human milk samples showed detectable levels of 4-OH-BP (Lopez et al., J Matern Fetal Neonatal Med, 2016; 29(S1): 1–317 and also in Lopez et al., Eur J Pediatr, 2016, 175:1393–1880).
4-OH-BP was detected in human seminal plasma and urine. There was no association between 4-OH-BP levels and couple fecundability observed (Louis et al.,Environmental Research 163, 2018, 64-70).
Read-across data captured from published Benzophenone registration dossier:
Oral OECD rats two gen (Guideline 416): No reproductive toxicity was found and effects on the offspring (inhibition of body weights) were observed at the highest dose only. LOAEL: 6 mg/kg bw based on the dose-dependent histopathological findings in liver of adult rats (Hoshino et al., 2005, J Toxicol Sci 30, 5-20).
Oral rabbits (OECD Guideline 414) and OPPTS 870.3700 rabbits prenatal development studies: Developmental toxicity was noted only in the presence of well-defined maternal toxicity. There was no evidence for selective susceptibility of the conceptus relative to the pregnant dam.
Receptor binding/estrogenicity/uterotrophic assay
4-HO-BP has a weak androgen receptor binding affinity (Receptor binding assay) (Fang et al., Chem. Res. Toxicol. 2003, 16, 1338-1358)
4-HO-BP has a strong estrogen activity (Yeast two hybrid assay) (Kawamura et. al, Journal of Health Science,49(3) 205-212 (2003))
4-HO-BP has no/very weak androgen receptor activity (hAR Mediated Reporter Gene Agonist Assay), estrogenic activity (hERα Mediated reporter gene agonist assay). Kawamura et al. (Journal of Health Science, 51(1) 48-54 (2005).
Estrogenicity was measured colormetrically as ß-galactosidase activity. 4-HO-BP exhibited weak ß-galactosidase activity (Schultz, Environmental Toxicology and Chemistry, Vol. 19, No. 2, pp. 301-304. 2000)
4-HO-BP exhibited estrogenic activity in the estrogen screening assay. No androgenic activity of 4-HO-BP was observed in the concentration range of 10-7to 10-4M in vitro (Suzuki et al., Toxicology and Applied Pharmacology 203, 2005, 9 – 17).
4OH-BP showed potent estrogenic activity inducing a response from 10-6M in CXCL-testing, a cell proliferation test (Hebauzit et al., Chemosphere 173 (2017) 253-260)
Administration (s.c.) of 100-400 mg/kg bw 4-HO-BP elicited an increase in absolute and relative uterine weights in a dose dependent manner accompanied by an increase in luminal epithelial height and stromal cells in the uterus and an increase in thickness of vaginal epithelial cell layers with cornification in juvenile female rats (21-days old, administration for 3 days) (Nagakawa, Arch Toxicol (2001) 75: 74-79)
4-HO-BP was positive in the reporter gene assay for ER-alpha agonists. Uterine blotted weight decreased significantly in rats given 200 mg/kg bw 4-HO-BP plus ethinyl-estradiol in an uterotrophic assay (Yamasaki et al., Toxicology Letters 142, 2003, 119-131)
4-HO-BP exerted both estrogen agonistic effect and reduced the estrogenic effect of ethinylestradiol in the uterotrophic assay (Yamasaki et al., Toxicology 183, 2003, 93-115)
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
4-HO-BP gave positive results in several uterotrophic and receptor binding assays. Nevertheless, there was no indication for reproductive toxicity in several epidemiological studies. Also the read across data from a 2-generation study with benzophenone as test compound gave no indication for reproductive toxicity. It must be considered, that the high dose of the 2-generation study (150 mg/kg bw/d) was below the effective concentration in uterotrophic assays with benzophenone as test compound (300 mg/kg bw/d). Additionally, since benzophenone was administered via the feed, likely no peak concentrations of its metabolite 4 -OH-BP occured in this study.
Consequently, the RA data is insufficient to exclude an estrogenic potential of hydroxybenzophenone, nevertheless the available data is insufficient for reproductive toxicity classification purposes under Regulation (EC) No 1272/2008, as amended for the seventh time in Regulation (EU) No 2015/1221.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.